Halozyme Therapeutics
HALO
#2173
Rank
S$9.56 B
Marketcap
$77.69
Share price
1.35%
Change (1 day)
60.61%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2023 (TTM): $2.38

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is $2.32. In 2022 the company made an earnings per share (EPS) of $1.98 a decrease over its 2021 EPS that were of $3.80.

EPS history for Halozyme Therapeutics from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.3820.43%
2022$1.98-48.07%
2021$3.80196.88%
2020$1.28-292%
2019-$0.67-9.09%
2018-$0.73-237.5%
2017$0.53-149.38%
2016-$1.08211.54%
2015-$0.35-52.73%
2014-$0.73-24.66%
2013-$0.9748.98%
2012-$0.65145%
2011-$0.27-64.29%
2010-$0.75-17.65%
2009-$0.919.68%
2008-$0.8393.75%
2007-$0.4333.33%
2006-$0.32-4%
2005-$0.33-3.85%
2004-$0.35-13.33%
2003-$0.4083.59%
2002-$0.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.25-110.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.25 212.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.83 194.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.48 6.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.24 82.77%๐Ÿ‡ซ๐Ÿ‡ท France
$18.80 709.50%๐Ÿ‡บ๐Ÿ‡ธ USA